title: Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes.
abstract: Human T-cell lymphotropic virus type II (HTLV-II) has been subtyped into two major groups, IIa and IIb, according to molecular studies involving env gene sequencing. Subsequently, this retrovirus was further subclassified by examining the long terminal repeat (LTR), the most divergent genomic region. Sequence analysis and restriction fragment-length polymorphism (RFLP) applied to the LTR region identified either four or five groups within the IIa subtype (depending on the restriction enzyme sets used) and six within the IIb subtype. In this study, we analyzed the LTR sequences of 29 samples obtained from HTLV-II-infected individuals living in Spain and Italy, which included 24 injecting drug users (IDUs), three blood donors, and two subjects at risk for HIV/HTLV infection. Sequence analysis and phylogenetic analysis of 720 base pairs of the LTR performed in 10 Spanish samples showed that all of these samples belonged to IIb subtype, with a divergence of 7.5% and 1.66% compared with MoT (IIa) and NRA/G12 (IIb) isolates, respectively. RFLP analysis demonstrated the presence of the IIb 4-subtype restriction pattern in 26 samples, a IIb5-subtype pattern in one Italian IDU, and a IIa0-subtype pattern in two Italian samples (blood donors), according to W.M. Switzer's nomenclature. This is the first report of the presence of IIb5 in Southern Europe and IIa0 among Italian blood donors. RFLP correlated with nucleotide sequence and phylogenetic data obtained in this study, demonstrating the ability of the RFLP method to predict the phylogroup of HTLV-II-infected samples.
authors.affiliation: Laboratory of Molecular Virology, CBER/FDA, Rockville, Maryland, USA.
authors.forename: A
authors.initials: A
authors.lastname: Vallejo
authors.forename: P
authors.initials: P
authors.lastname: Ferrante
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: M L
authors.initials: ML
authors.lastname: Calabrò
authors.forename: R
authors.initials: R
authors.lastname: Mancuso
authors.forename: A
authors.initials: A
authors.lastname: Heredia
authors.forename: E
authors.initials: E
authors.lastname: Mannella
authors.forename: A
authors.initials: A
authors.lastname: Favero
authors.forename: A
authors.initials: A
authors.lastname: Garcia-Sáiz
authors.forename: L
authors.initials: L
authors.lastname: Chieco-Bianchi
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
authors.forename: I K
authors.initials: IK
authors.lastname: Hewlett
mesh_terms: D001483:Base Sequence; D001782:Blood Donors; D017931:DNA Primers; D004279:DNA, Viral / Q000032:analysis*; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015491:HTLV-II Infections / Q000453:epidemiology / Q000235:genetics*; D015367:Human T-lymphotropic virus 2 / Q000145:classification* / Q000235:genetics*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008969:Molecular Sequence Data; D010802:Phylogeny; D012150:Polymorphism, Restriction Fragment Length; D013030:Spain / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000453:epidemiology
chemical_list: D017931:DNA Primers; D004279:DNA, Viral